Hostname: page-component-745bb68f8f-lrblm Total loading time: 0 Render date: 2025-01-12T03:59:23.179Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticholinergic Anti-Parkinson Medication for Neuroleptic-induced Extrapyramidal Side Effects

Published online by Cambridge University Press:  29 January 2018

Som D. Soni  and
D. A. W. Johnson
Som D. Soni
Affiliation:
Prestwich Hospital, Manchester M25 8BL
D. A. W. Johnson
Affiliation:
Withington Hospital, Manchester
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 149 , Issue 3 , September 1986 , pp. 386
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Altamura, A. C. et al. (1983) Italian Society of Biological Psychiatry. In Disipal in the Neuroleptic Syndrome, West Byfleet, Surrey: Brocades (Great Britain).Google Scholar
Bamrah, J. S., Kumar, V., Krska, J. & Soni, S. D. (1986) Interaction between procyclidine and neuroleptic drugs: some pharmacological and clinical aspects. British Journal of Psychiatry (in press).CrossRefGoogle Scholar
Johnson, D. A. W. (1985) Antipsychotic medication: Clinical guidelines for maintenance therapy. Journal of Clinical Psychiatry, 5, 6–15.Google Scholar
Lader, M. (1980) Introduction to Psychopharmacology. A ‘Scope’ Publication. Kalamazoo, Michigan: Upjohn Company.Google Scholar
Shader, R. I. Greenblatt, D. J. (1971) Uses and toxicity of bellandonna alkaloids and synthetic anticholinergics. Seminars in Psychiatry, 3, 449–76.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.